Strain Summary(A/Flaks x C57BL)F1

Strain Name

 (A/Flaks x C57BL)F1

Strain Type(s)

 hybrid

Strain Synonym(s)

 ABF1  •  (AF x C57Bl)F1

Description

 F1 generation of a cross between A/Flaks female and C57BL (unspecified strain) male mice.

Models

12 unique models displayed. A model is a set of tumors that share the same tumor name, organ(s) affected, and treatment type for a specific strain.
Frequency
Model Name Organ Affected Tumor Inducing Agent(s) Female Male Mixed Pop. Unspecified Additional Information Model Details
Connective tissue - Fibroblast fibrosarcoma Connective tissue - Fibroblast 9,10-dimethyl-1,2-benzanthracene (DMBA)

3.8

9.1

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Leukocyte - Lymphocyte lymphoma - small lymphocytic Leukocyte - Lymphocyte 9,10-dimethyl-1,2-benzanthracene (DMBA)

4.5

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Leukocyte leukemia Leukocyte

0

0

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Leukocyte leukemia Leukocyte 9,10-dimethyl-1,2-benzanthracene (DMBA)

38

59

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Liver hepatoma Liver

0

0

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Liver hepatoma Liver 9,10-dimethyl-1,2-benzanthracene (DMBA)

3.8

4.5

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Liver hepatoma - malignant Liver 9,10-dimethyl-1,2-benzanthracene (DMBA)

0

0

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Lung adenoma Lung

17

12

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Lung adenoma Lung 9,10-dimethyl-1,2-benzanthracene (DMBA)

96

100

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Lung carcinoma Lung 9,10-dimethyl-1,2-benzanthracene (DMBA)

7.7

14

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Mammary gland carcinoma Mammary gland 9,10-dimethyl-1,2-benzanthracene (DMBA)

0

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85

Ovary carcinoma Ovary 9,10-dimethyl-1,2-benzanthracene (DMBA)

7.7

References: Flaks A, Eur J Cancer 1968 Dec;4(6):579-85